Drug
Aducanumab
Aducanumab: highest development phase Phase 3, developed by Biogen. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Aducanumab NCT05310071 | Phase 3 | Alzheimer's Disease |
| Aducanumab NCT04241068 | Phase 3 | Alzheimer's Disease |
Latest
No recent events.
Follow Aducanumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.